Our verdict
VivioMD advertises clinician-reviewed GLP-1 care with flat pricing across doses. Its public pages give no medication name or price, and cancellation requires 72 hours’ notice before billing.
Main trade-offs
- No price on its public pages
- Doesn't name the medication or the pharmacy before you sign up
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
FDA warning letter on record — read the public record and the context below.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Buyers who are comfortable learning the price during sign-up and want a flat rate at every dose with a refund if they're disqualified.
Consider other options if
Anyone who wants to compare published prices, know the exact drug and pharmacy in advance, or live in Louisiana.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- No price on its public pages; flat pricing promised at every dose. 49 states, not Louisiana
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- 49 states (not Louisiana)
Our review in detail
Full assessment
VivioMD makes a set of reasonable promises: a licensed provider, flat pricing that doesn't climb as your dose goes up, free shipping, HSA and FSA eligibility, 24/7 messaging and a full refund if you're disqualified. What it doesn't do is tell you, before you start the assessment, what you'll pay or which drug you'll get. Its public pages name no medication and list no price, describing only "brand-name and personalized options". That leaves you comparing it on trust rather than numbers. Its cancellation terms are typical for the category: 72 hours' notice before billing, and no refund on a monthly plan once the month has started. The FDA sent VivioMD a warning letter in June 2026 about how its website presented compounded semaglutide and tirzepatide. If price transparency matters, it's worth comparing a service that prints its rates.
What it is
VivioMD Group LLC runs the website and the non-clinical side of the program; it says it isn't a pharmacy or a drug manufacturer. Clinical care comes from U.S.-licensed clinicians at OpenLoop Healthcare Partners P.C. and its affiliated medical groups, which decide eligibility. Medication is dispensed by independent, state-licensed compounding and retail pharmacies, none of them named. The FDA letter addresses the company at an address in Lewes, Delaware, and its customer service runs weekdays on Central time. The homepage says its providers are licensed in all 50 states, but the terms say services are offered in 49 states and aren't available in Louisiana. It's cash-pay: insurance isn't required, and HSA and FSA payments are accepted. The footer links to LegitScript's public checker but displays no seal number, so look the company up yourself if certification matters to you. Its published terms of use also refer to dispute-resolution and other standard sections that the posted page doesn't include.
How care works
You start with a five-minute online assessment. A licensed provider from the partner medical group reviews it, with same-day review promised when you qualify, and the site describes a provider consultation as part of the process and a live consult as included with every plan. If you're approved, the prescription goes to a state-licensed pharmacy and ships free and discreetly to your door. After that you have ongoing access to the care team and clinicians, including 24/7 messaging, regular check-ins and dose adjustments as you progress. Medication orders may be sent to the pharmacy automatically once a provider approves your prescription, and the terms note that you can cancel a medication subscription only before an order is placed. The homepage also offers to let you talk to a licensed provider first if you're unsure whether treatment fits you.
Costs, billing and cancellation
No price appears on VivioMD's homepage or any of its public policy pages. The only pricing statements are promises: flat pricing that never goes up as your dose increases, transparent pricing with no hidden fees, free shipping, and a summer promotion banner advertising $100 off. Expect to see the actual cost during sign-up. Membership begins once you complete the intake and pay for the first month, and plans are billed in advance for the period you choose, monthly, quarterly or annual, renewing automatically at the then-current rate. Quarterly billing is easy to miss, and the Peter MD review shows tirzepatide at $149 for the first month, then $249 a month billed quarterly. If you took a discount tied to a minimum commitment and cancel early, the discount is forfeited and completed months are recalculated at full price. To cancel, email support or use your patient portal at least 72 hours before your next billing date; otherwise you're charged once more and the cancellation takes effect the following cycle. You get a full refund if you cancel within 72 hours of starting and haven't received any services, or if a provider disqualifies you. Monthly plans aren't refunded for the current or prior months; multi-month plans are refunded for months in which no medication shipped.
Medication and evidence
VivioMD's public pages describe "top GLP-1 treatments, brand-name and personalized options", and its footer says a provider may prescribe a compounded medication, prepared by independent compounding pharmacies, which isn't FDA-approved. It doesn't name a molecule. The FDA's June 2026 warning letter states that when the agency reviewed the website in March 2026, it offered compounded semaglutide and tirzepatide products. The letter said product images labeled "VivioMD" suggested the company was the compounder when it is not, and it found those representations false or misleading under federal law. The site today carries a disclaimer that packaging images are illustrations and that VivioMD isn't a pharmacy or manufacturer. The letter is disclosed and linked on this page. Ask which medication, strength and pharmacy you'd receive before you pay.
FDA warning letter on record
The FDA issued a warning letter naming VivioMD Group LLC dba VivioMD, the company behind VivioMD.
- Letter 728295, issued June 8, 2026 — read it on fda.gov
We publish this because it is a matter of public record and a reader weighing this provider should have it. A warning letter is the FDA setting out alleged violations; it is not a court finding, and a company may have responded or corrected since. It does not remove VivioMD from this site, and it does not change our verdict — read the letter and decide for yourself.
Pros and watch-outs
What we like
- Flat pricing promised at every dose, with free shipping
- Full refund if a provider disqualifies you
- Clinicians from a named national medical group
- 24/7 messaging with the care team
- HSA and FSA eligible
Watch-outs
- No price on its public pages
- Doesn't name the medication or the pharmacy before you sign up
- Monthly plans aren't refunded once the month has started
- Cancellation needs 72 hours' notice before billing
- FDA warning letter in June 2026 over compounded-drug claims
Best for
Buyers who are comfortable learning the price during sign-up and want a flat rate at every dose with a refund if they're disqualified.
Who should look elsewhere
Anyone who wants to compare published prices, know the exact drug and pharmacy in advance, or live in Louisiana.
Research relevant to VivioMD
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
SURMOUNT-5 found 20.2% versus 13.7% average weight loss. What that direct comparison supports, which doses it tested, and why newer formulations need separate evidence.
- Compounded vs branded GLP-1: regulatory status, sourcing and the evidence
Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.
How VivioMD compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our CoreAge Rx review and Oak Longevity review describe what each service publishes about pricing, billing and cancellation.
CoreAge RxPublished starting prices with written plan and billing confirmation
See CoreAge Rx →- Oak Longevity
Compounded or branded options with a written medication, plan and renewal quote
See Oak Longevity → VitaraRx
Cash buyers who want one compounded price at every dose and a named dispensing pharmacy
See VitaraRx →
More GLP-1 telehealth reviews: EmbodyCollectiveWholesome ClinicWillowPCOS SistersCeliaRx
Access & cost
How we assessed this. This review is based on VivioMD’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does VivioMD cost?
- VivioMD doesn't publish a price on its public pages. It promises flat pricing that doesn't rise with your dose and free shipping, and you see the cost during sign-up.
- Can I cancel VivioMD anytime?
- Yes, by email or through your portal, but the request must arrive at least 72 hours before your next billing date. Service continues to the end of the paid cycle.
- Does VivioMD give refunds?
- A full refund applies if a provider disqualifies you, or if you cancel within 72 hours of starting before receiving any services. Monthly plans aren't otherwise refunded.
- Which states is VivioMD available in?
- Its terms list 49 states and exclude Louisiana, although the homepage says its providers are licensed in all 50.
- Has VivioMD received an FDA warning letter?
- Yes. In June 2026 the FDA warned VivioMD Group that product images on its website suggested it compounded the semaglutide and tirzepatide it offered, when it does not.
- Is VivioMD legit?
- FDA has a warning letter on record against VivioMD Group LLC dba VivioMD, the company behind VivioMD, issued June 8, 2026 as letter 728295; it is linked further down this page. A warning letter is a public record worth reading. It doesn't by itself mean you can't use this provider. VivioMD is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: No price on its public pages; flat pricing promised at every dose. 49 states, not Louisiana. It is cash-pay and states it does not bill insurance. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.
